I would agree with that. Yes.
As I said earlier, we can be quite sophisticated about stockpiling. We have to look at all the inputs. It's not just the fill and finish of the tablet and the drug itself; there's the active pharmaceutical ingredient, mostly sourced from India and China, that we know about. Oftentimes, that's a rate-limiting step in the manufacture of product, be it a supply of active pharmaceutical ingredient, be it some kind of manufacturing redundancy or be it true physical stockpiles of certain select critical medications.
That's something we definitely need to look into.